Company · CIK 0000886163 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
LIGAND PHARMACEUTICALS INC · LGND
Insider activity reported against this company. All insider holders · Files at: VKTX. On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 22, 2026 FForm 4 → | Sep 24, 5:22 pm EDT | Martine ZimmermannDirector | 115 | $298.50 | $34,328 | 3,782 | — | |
| Sep 10, 2026 SForm 4 → | Sep 14, 4:59 pm EDT | Martine ZimmermannDirector | 1,200 | $285.00 | $342,000 | 3,897 | −23.5% | |
| Sep 3, 2026 SForm 4 → | Sep 8, 6:34 pm EDT | Andrew ReardonCLO & Secretary | 5,000 | $286.09 | $1,430,434 | 36,514 | −12.0% | 10b5-1 |
| Aug 12, 2026 SForm 4 → | Aug 14, 5:05 pm EDT | Octavio EspinozaChief Financial Officer | 31,641 | $292.07 | $9,241,229 | 27,696 | −53.3% | 10b5-1 |
| Aug 12, 2026 MForm 4 → | Aug 14, 5:05 pm EDT | Octavio EspinozaChief Financial Officer | 31,641 | $56.91 | $1,800,574 | 59,337 | — | 10b5-1 |
| Aug 12, 2026 SForm 4 → | Aug 14, 5:04 pm EDT | Jason HaasDirector | 7,138 | $292.81 | $2,090,062 | 3,981 | −64.2% | |
| Aug 12, 2026 MForm 4 → | Aug 14, 5:04 pm EDT | Jason HaasDirector | 6,138 | $51.56 | $316,475 | 11,119 | — | |
| Aug 3, 2026 SForm 4 → | Aug 4, 6:42 pm EDT | Andrew ReardonCLO & Secretary | 5,000 | $288.99 | $1,444,951 | 41,514 | −10.7% | 10b5-1 |
| Aug 3, 2026 MForm 4 → | Aug 4, 6:42 pm EDT | Andrew ReardonCLO & Secretary | 5,000 | $52.27 | $261,350 | 46,514 | — | 10b5-1 |
| Jul 1, 2026 SForm 4 → | Jul 6, 5:11 pm EDT | Andrew ReardonCLO & Secretary | 5,000 | $313.28 | $1,566,377 | 41,514 | −10.7% | 10b5-1 |
| Jun 30, 2026 JMForm 4 → | Jul 6, 5:11 pm EDT | Andrew ReardonCLO & Secretary | 5,132 | $55.06 | $282,564 | 46,514 | — | 10b5-1 late |
| Jun 30, 2026 JForm 4 → | Jul 6, 5:11 pm EDT | Octavio EspinozaChief Financial Officer | 17 | $160.71 | $2,732 | 27,696 | — | late |
| Jun 30, 2026 JForm 4 → | Jul 6, 5:10 pm EDT | Todd C DavisChief Executive Officer, Director | 132 | $160.71 | $21,214 | 199,513 | — | late |
| Jun 16, 2026 SForm 4 → | Jun 18, 8:37 am EDT | Stephen L SabbaDirector | 2,145 | $254.00 | $544,830 | 33,629 | −6.00% | |
| Jun 16, 2026 MForm 4 → | Jun 18, 8:37 am EDT | Stephen L SabbaDirector | 2,145 | $66.13 | $141,849 | 35,774 | — | |
| Jun 12, 2026 SForm 4 → | Jun 15, 9:06 pm EDT | Jason HaasDirector | 6,461 | $255.58 | $1,651,320 | 4,981 | −56.5% | |
| Jun 12, 2026 MForm 4 → | Jun 15, 9:06 pm EDT | Jason HaasDirector | 4,000 | $51.56 | $206,240 | 11,442 | — | |
| Jun 10, 2026 SForm 4 → | Jun 12, 5:27 pm EDT | Jason AryehDirector | 5,000 | $250.00 | $1,250,000 | 102,580 | −4.65% | |
| Jun 10, 2026 SForm 4 → | Jun 12, 5:26 pm EDT | John L LamattinaDirector | 4,591 | $250.88 | $1,151,774 | 26,969 | −14.5% | |
| Jun 5, 2026 AForm 4 → | Jun 12, 5:27 pm EDT | Jason AryehDirector | 836 | — | — | 107,580 | — | late |
| Jun 5, 2026 AFForm 4 → | Jun 9, 7:42 pm EDT | Martine ZimmermannDirector | 1,018 | $237.00 | $43,134 | 5,097 | — | |
| Jun 5, 2026 AForm 4 → | Jun 9, 7:41 pm EDT | Stephen L SabbaDirector | 836 | — | — | 33,629 | — | |
| Jun 5, 2026 AForm 4 → | Jun 9, 7:41 pm EDT | John L LamattinaDirector | 836 | — | — | 31,560 | — | |
| Jun 5, 2026 AForm 4 → | Jun 9, 7:40 pm EDT | John W KozarichDirector | 836 | — | — | 42,622 | — | |
| Jun 5, 2026 AForm 4 → | Jun 9, 7:35 pm EDT | Jason HaasDirector | 836 | — | — | 7,442 | — | |
| Jun 5, 2026 AForm 4 → | Jun 9, 7:35 pm EDT | Nancy Ryan GrayDirector | 836 | — | — | 8,930 | — |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 12, 2026 MForm 4 → | Aug 14, 5:05 pm EDT | Octavio EspinozaChief Financial Officer | 31,641 | — | — | 0 | — | 10b5-1 |
| Aug 12, 2026 MForm 4 → | Aug 14, 5:04 pm EDT | Jason HaasDirector | 6,138 | — | — | 0 | — | |
| Aug 3, 2026 MForm 4 → | Aug 4, 6:42 pm EDT | Andrew ReardonCLO & Secretary | 5,000 | — | — | 29,444 | — | 10b5-1 |
| Jul 1, 2026 MForm 4 → | Jul 6, 5:11 pm EDT | Andrew ReardonCLO & Secretary | 5,000 | — | — | 34,444 | — | 10b5-1 |
| Jun 16, 2026 MForm 4 → | Jun 18, 8:37 am EDT | Stephen L SabbaDirector | 2,145 | — | — | 0 | — | |
| Jun 12, 2026 MForm 4 → | Jun 15, 9:06 pm EDT | Jason HaasDirector | 4,000 | — | — | 6,138 | — | |
| Jun 5, 2026 AForm 4 → | Jun 12, 5:27 pm EDT | Jason AryehDirector | 2,938 | — | — | 2,938 | — | late |
| Jun 5, 2026 AForm 4 → | Jun 9, 7:42 pm EDT | Martine ZimmermannDirector | 2,938 | — | — | 2,938 | — | |
| Jun 5, 2026 AForm 4 → | Jun 9, 7:41 pm EDT | Stephen L SabbaDirector | 2,938 | — | — | 2,938 | — | |
| Jun 5, 2026 AForm 4 → | Jun 9, 7:41 pm EDT | John L LamattinaDirector | 2,938 | — | — | 2,938 | — | |
| Jun 5, 2026 AForm 4 → | Jun 9, 7:40 pm EDT | John W KozarichDirector | 2,938 | — | — | 2,938 | — | |
| Jun 5, 2026 AForm 4 → | Jun 9, 7:35 pm EDT | Jason HaasDirector | 2,938 | — | — | 2,938 | — | |
| Jun 5, 2026 AForm 4 → | Jun 9, 7:35 pm EDT | Nancy Ryan GrayDirector | 2,938 | — | — | 2,938 | — |
Filed by this entity as an insider elsewhere — common stock
No reported common-stock activity in this period.
Filed by this entity as an insider elsewhere — derivatives (options, RSUs, warrants)
No reported derivative activity in this period.